Cargando…
Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses
Autores principales: | Tendilla-Beltrán, Hiram, Carbajal-Rimoldi, Linda Alejandra, Flores, Francisco, Gómez-Mendoza, Laura Eréndira, Loaiza, Guillermo, Flores, Gonzalo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116153/ https://www.ncbi.nlm.nih.gov/pubmed/37098446 http://dx.doi.org/10.1016/j.genhosppsych.2023.04.009 |
Ejemplares similares
-
Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020) -
Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021) -
Increased suicide rates in Mexico City during the COVID-19 pandemic outbreak: An analysis spanning from 2016 to 2021
por: García-Dolores, Fernando, et al.
Publicado: (2023) -
Editorial: Non-canonical pathways of psychiatric drugs: beyond their neurotransmitter action
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2023) -
Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016)